• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索利用经济证据为疾病预防投资提供信息——一项定性研究。

Exploring the use of economic evidence to inform investment in disease prevention - a qualitative study.

机构信息

The George Institute for Global Health, University of New South Wales.

School of Public Health, The University of Sydney, New South Wales.

出版信息

Aust N Z J Public Health. 2018 Apr;42(2):200-206. doi: 10.1111/1753-6405.12748. Epub 2017 Dec 13.

DOI:10.1111/1753-6405.12748
PMID:29630786
Abstract

OBJECTIVE

In the context of growing financial pressures on health budgets, cost-effective prevention strategies are needed to address the burden from non-communicable disease in Australia. We explored how decision makers use economic evidence to inform such investment and how such evidence generated can more effectively meet the needs of end users.

METHODS

Thematic analysis of in-depth interviews with 15 high level stakeholders (Treasury, state health departments and the insurance industry), supplemented by documentary analysis.

RESULTS

Types of prevention approaches and economic evidence relevant to decision makers differed by organisational perspective. Capacity building in understanding economic evaluations and research evidence that addresses the differing criteria for investment used by different organisations is needed. The task of determining investment priorities in disease prevention comes with significant challenges including ideological barriers, delayed outcome measures, and implementation uncertainties. Conclusions and Implications for public health: Promoting the greater use of economic evidence in prevention requires more work on two fronts: tailoring the methods used by economists to better match the organisational imperatives of end users; and promoting greater consideration of broader societal and health sector perspectives among end users. This will require significant infrastructure development, monitoring and evaluation, stronger national leadership and a greater emphasis on evidence coproduction.

摘要

目的

在卫生预算面临日益增长的财政压力的背景下,需要采取具有成本效益的预防策略来应对澳大利亚非传染性疾病的负担。本研究旨在探讨决策者如何利用经济证据来为这类投资提供信息,以及如何更有效地生成此类证据以满足最终用户的需求。

方法

对 15 名高级利益相关者(财政部、州卫生部门和保险行业)进行深入访谈的主题分析,并辅以文献分析。

结果

不同组织视角下的预防方法和经济证据的类型不同。需要加强决策者对经济评估和研究证据的理解,这些证据应考虑到不同组织用于投资的不同标准。确定疾病预防投资重点的任务面临着重大挑战,包括思想障碍、延迟的结果衡量指标和实施的不确定性。

结论和对公共卫生的启示

要促进在预防中更多地使用经济证据,需要在两个方面开展更多工作:调整经济学家使用的方法,使其更好地符合最终用户的组织要求;促进最终用户更多地考虑更广泛的社会和卫生部门的观点。这将需要大量的基础设施发展、监测和评估、更强有力的国家领导以及更加注重证据的共同生产。

相似文献

1
Exploring the use of economic evidence to inform investment in disease prevention - a qualitative study.探索利用经济证据为疾病预防投资提供信息——一项定性研究。
Aust N Z J Public Health. 2018 Apr;42(2):200-206. doi: 10.1111/1753-6405.12748. Epub 2017 Dec 13.
2
A cost-benefit analysis framework for preventive health interventions to aid decision-making in Australian governments.用于辅助澳大利亚政府决策的预防性健康干预措施的成本效益分析框架。
Health Res Policy Syst. 2021 Dec 19;19(1):147. doi: 10.1186/s12961-021-00796-w.
3
Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders预防和治疗精神、神经及物质使用障碍的干预措施、政策和平台的成本效益及可负担性
4
What will it take to improve prevention of chronic diseases in Australia? A case study of two national approaches.如何才能改善澳大利亚慢性病的预防工作?对两种国家方法的案例研究。
Aust Health Rev. 2017 May;41(2):176-181. doi: 10.1071/AH16002.
5
6
Preventive health resource allocation decision-making processes and the use of economic evidence in an Australian state government-A mixed methods study.澳大利亚州政府的预防性卫生资源分配决策过程和经济证据的使用——一项混合方法研究。
PLoS One. 2022 Sep 19;17(9):e0274869. doi: 10.1371/journal.pone.0274869. eCollection 2022.
7
Exploring the role of economics in prioritization in public health: what do stakeholders think?探讨经济学在公共卫生优先级排序中的作用:利益相关者的想法是什么?
Eur J Public Health. 2011 Oct;21(5):578-84. doi: 10.1093/eurpub/ckq121. Epub 2010 Sep 3.
8
Organizational determinants of evaluation practice in Australian prevention agencies.澳大利亚预防机构评价实践的组织决定因素。
Health Educ Res. 2018 Jun 1;33(3):243-255. doi: 10.1093/her/cyy015.
9
Implementing and using quality measures for children's health care: perspectives on the state of the practice.实施和使用儿童保健质量指标:实践现状透视
Pediatrics. 2004 Jan;113(1 Pt 2):217-27.
10
Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study.经济评估在药品管理委员会的决策中起作用吗?一项定性研究。
Pharm World Sci. 2007 Dec;29(6):661-70. doi: 10.1007/s11096-007-9125-z. Epub 2007 Jun 14.

引用本文的文献

1
Including climate change in community-based obesity prevention interventions: a qualitative exploration of the perspectives of Australian funders.将气候变化纳入基于社区的肥胖预防干预措施:对澳大利亚资助者观点的定性探索
BMC Public Health. 2025 Apr 24;25(1):1526. doi: 10.1186/s12889-025-22599-2.
2
How should non-emergency EMS presentations be managed? A thematic analysis of politicians', policymakers', clinicians' and consumers' viewpoints.非紧急情况下的急救医疗服务应如何管理?对政治家、政策制定者、临床医生和消费者观点的主题分析。
BMJ Open. 2024 Jul 25;14(7):e083866. doi: 10.1136/bmjopen-2024-083866.
3
The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review.
评价基于社区的健康促进的经济方面的局限性和潜力:批判性回顾。
Appl Health Econ Health Policy. 2024 Mar;22(2):165-179. doi: 10.1007/s40258-023-00864-y. Epub 2024 Jan 8.
4
Preventive health resource allocation decision-making processes and the use of economic evidence in an Australian state government-A mixed methods study.澳大利亚州政府的预防性卫生资源分配决策过程和经济证据的使用——一项混合方法研究。
PLoS One. 2022 Sep 19;17(9):e0274869. doi: 10.1371/journal.pone.0274869. eCollection 2022.
5
Toward the economic evaluation of participatory approaches in health promotion: lessons from four German physical activity promotion projects.迈向健康促进中参与式方法的经济评估:来自四个德国身体活动促进项目的经验教训。
Health Promot Int. 2021 Dec 13;36(Supplement_2):ii79-ii92. doi: 10.1093/heapro/daab158.